SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-140622
Filing Date
2021-04-29
Accepted
2021-04-29 16:40:04
Documents
12
Period of Report
2021-04-27
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d181374d8k.htm   iXBRL 8-K 34024
  Complete submission text file 0001193125-21-140622.txt   161124

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA acet-20210427.xsd EX-101.SCH 3094
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE acet-20210427_lab.xml EX-101.LAB 18888
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acet-20210427_pre.xml EX-101.PRE 11876
5 EXTRACTED XBRL INSTANCE DOCUMENT d181374d8k_htm.xml XML 3468
Mailing Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116
Business Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116 617-482-2333
Adicet Bio, Inc. (Filer) CIK: 0001720580 (see all company filings)

IRS No.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38359 | Film No.: 21871398
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences